# Home-administered tDCS for Treatment of Depression

> **NCT04781127** · PHASE1 · COMPLETED · sponsor: **Soterix Medical** · enrollment: 50 (actual)

## Conditions studied

- Unipolar Depression
- Treatment Resistant Depression

## Interventions

- **DEVICE:** Soterix Medical mini-CT tDCS stimulator

## Key facts

- **NCT ID:** NCT04781127
- **Lead sponsor:** Soterix Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-10
- **Primary completion:** 2022-08-10
- **Final completion:** 2022-08-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04781127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04781127, "Home-administered tDCS for Treatment of Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04781127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*